Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Smyth

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
JAMA Internal Medicine|October 9, 2013
A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trialMartin Than, Sally Aldous, Sarah Jane Lord, et al.
Circulation|October 19, 2020
Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy BalanceHan-Bin Lin, Kotaro Naito, Yena Oh, et al.
Nature Cardiovascular Research|August 28, 2024
Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failureLiyong Zhang, David Smyth, Mohammad Al-Khalaf, et al.
Nature Cardiovascular Research|March 13, 2026
Hematopoietic expression of cIAP2 drives inflammation and heart failure after myocardial infarctionDavid Smyth, Liyong Zhang, Mohammad Al-Khalaf, et al.
Nature Medicine|August 13, 2013
Local proliferation dominates lesional macrophage accumulation in atherosclerosisClinton S Robbins, Ingo Hilgendorf, Georg F Weber, et al.
American Heart Journal|June 4, 2023
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trialJung-Min Ahn, Do-Yoon Kang, Pil Hyung Lee, et al.
European Heart Journal|May 29, 2025
Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trialMin Chul Kim, Seung-Jung Park, Duk-Woo Park, et al.
Lancet (London, England)|April 11, 2024
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trialSeung-Jung Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Nature Metabolism|October 9, 2020
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
Nature Metabolism|September 29, 2020
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
JAMA Internal Medicine|October 9, 2013
A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trialMartin Than, Sally Aldous, Sarah Jane Lord, et al.
Circulation|October 19, 2020
Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy BalanceHan-Bin Lin, Kotaro Naito, Yena Oh, et al.
Nature Cardiovascular Research|August 28, 2024
Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failureLiyong Zhang, David Smyth, Mohammad Al-Khalaf, et al.
Nature Cardiovascular Research|March 13, 2026
Hematopoietic expression of cIAP2 drives inflammation and heart failure after myocardial infarctionDavid Smyth, Liyong Zhang, Mohammad Al-Khalaf, et al.
Nature Medicine|August 13, 2013
Local proliferation dominates lesional macrophage accumulation in atherosclerosisClinton S Robbins, Ingo Hilgendorf, Georg F Weber, et al.
American Heart Journal|June 4, 2023
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trialJung-Min Ahn, Do-Yoon Kang, Pil Hyung Lee, et al.
European Heart Journal|May 29, 2025
Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trialMin Chul Kim, Seung-Jung Park, Duk-Woo Park, et al.
Lancet (London, England)|April 11, 2024
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trialSeung-Jung Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Nature Metabolism|October 9, 2020
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
Nature Metabolism|September 29, 2020
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
Pageof 7